We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Transgenic System for Soil Remediation

By Biotechdaily staff writers
Posted on 29 Oct 2002
Researchers have developed the first transgenic system for removing arsenic from the soil by using genetically modified plants. More...
Their work was reported in the October 6, 2002, issue of Nature Biotechnology.

The researchers inserted two genes from the common bacterium Escherichia coli that allow a member of the mustard family called Arabidopsis to tolerate arsenic, usually lethal to plants. Arabidopsis can then remove arsenic from the soil and transport it to the plant's leaves in a form that is far less biologically available in the environment. When the healthy plants are harvested, much of the arsenic pollution, once in the soil, can be removed from the site. In tests, 96-100% of arsenic in leaves was reduced to arsenite and bound by sulphur, making the system highly effective.

Arsenic contamination is an enormous worldwide problem. The new strategy, called phytoredmediation, cleans polluted soil through the use of plants that sequester poisons and make them less harmful.

"Our data demonstrate the first significant increase in arsenic tolerance and what we call ‘hyperaccumulation' by genetically engineered plants,” said Dr. Richard Meagher, of the University of Georgia (Athens, USA; www.uga.edu) and one of the researchers.





Related Links:
University of Georgia

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Hematology Consumables
Bioblood Devices
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.